Uncategorized Ecorobotix has just announced the completion of a $52 million (CHF 46 million) funding round Uncategorized Keren Leshem is the new Board Member of our portfolio company Aspivix Uncategorized Guillaume Petit-Pierre, CEO and Co-Founder of Artiria Medical , will be presenting at the Innovation Summit Dublin 2023, one of the most prominent MedTech conference in Europe Uncategorized Our General Partner Bin Sheng was in Biopôle Lausanne to welcome the Hangzhou Delegation and help reinforce collaboration between Switzerland and China Uncategorized Scailyte annouces collaboration with Turnstone Biologics to identify biomarker signatures in solid tumor with TIL therapy Uncategorized Ecorobotix obtains once again the BCorp certification Uncategorized RQM+ has acquired Giotto Compliance from Giotto.AI, previously known as L2F Uncategorized Ecorobotix expanding its global footprint and growing its distribution network in Turkey, Spain, Denmark and Poland Uncategorized Aspivix team obtains the 510(k) clearance from the US FDA admnistration for Carevix, their novel cervical stabilizer that will help millions of American women and that offers an alternative to a painful century-old gynecological tool Uncategorized Swiss start-ups raised close to CHF 4Bn funding in 2022 despite a very tense economical and political environment. The Canton of Vaud attracted the major share of this funding with a record number of exits. Uncategorized Moderna is now recognized as Global Biotech Company of the Year Uncategorized The Swiss parliament made an urgent and necessary decision that paves the way for accepting medical devices certified by the FDA Uncategorized Artiria Medical has been selected as one of the highest rated company pitching at the Tech Tour Future Health event Uncategorized The Swiss Economic Forum has awarded the cleantech scale-up the quality label “SEF.Growth high potential”, which validates Ecorobotix’s high growth strategy Uncategorized 4FOX Ventures took part of the succesful USD 5M closing of the Serie A+ of our portfolio company Aspivix Uncategorized Our portfolio company Ecorobotix won the gold medal in robotics and embedded electronics at the prestigious SIMA Innovation Awards 2022 Uncategorized Our portfolio company Positrigo just secured a first closing of CHF 5.5M for its series B round, welcoming new investors and bringing the total amount raised to date to CHF 13M Uncategorized Despite all economic and geopolitical uncertainties, fundings for startups is at an all-time high. Uncategorized Switzerland is the most innovative country in the world, ahead of the US and Sweden, said the World Intellectual Property Organization (WIPO) Uncategorized Our portfolio company Scailyte has succesfully closed its Series A funding raising CHF 6 million from a Swiss family office, Mirabaud bank, and previous investors Uncategorized Aspivix has received the European Medical Device Regulation QMS certification and is on track to obtain CE marking for their Suction Cervical Stabilizer Uncategorized Welcome to Simon Aspinall who is now leading the ambitious development of our portfolio company Ecorobotix Uncategorized Interesting podcast by Hui Yang Goh, Senior Advisor Alternative Investments at Pictet Wealth Management on why to invest in healthcare via private equity funds Uncategorized Our portfolio company Artiria Medical secured a CHF 2.7M grant from one of the most competitive programs in Europe Uncategorized Venture Capital Funding in Switzerland has experienced a tremendous growth over the past 10 years and is expected to keep booming Uncategorized Our portfolio company Kairos Fire joined force with TF1 PUB to measure the impact of TV campaigns Uncategorized Our portfolio company, Aspivix, achieved a new great milestone through the completion of the comparative clinical trial phase contributing Uncategorized Our portfolio company, Neo Medical, closes Swisscom Ventures-lead USD 20.6M financing round Uncategorized Go and read the latest interview of Vincent Lefauconnier, CEO of our portfolio company Neomedical Uncategorized Our portfolio company Scailyte successfully closed its Serie A financing round, welcoming two additional new investors.
Uncategorized Ecorobotix has just announced the completion of a $52 million (CHF 46 million) funding round
Uncategorized Guillaume Petit-Pierre, CEO and Co-Founder of Artiria Medical , will be presenting at the Innovation Summit Dublin 2023, one of the most prominent MedTech conference in Europe
Uncategorized Our General Partner Bin Sheng was in Biopôle Lausanne to welcome the Hangzhou Delegation and help reinforce collaboration between Switzerland and China
Uncategorized Scailyte annouces collaboration with Turnstone Biologics to identify biomarker signatures in solid tumor with TIL therapy
Uncategorized Ecorobotix expanding its global footprint and growing its distribution network in Turkey, Spain, Denmark and Poland
Uncategorized Aspivix team obtains the 510(k) clearance from the US FDA admnistration for Carevix, their novel cervical stabilizer that will help millions of American women and that offers an alternative to a painful century-old gynecological tool
Uncategorized Swiss start-ups raised close to CHF 4Bn funding in 2022 despite a very tense economical and political environment. The Canton of Vaud attracted the major share of this funding with a record number of exits.
Uncategorized The Swiss parliament made an urgent and necessary decision that paves the way for accepting medical devices certified by the FDA
Uncategorized Artiria Medical has been selected as one of the highest rated company pitching at the Tech Tour Future Health event
Uncategorized The Swiss Economic Forum has awarded the cleantech scale-up the quality label “SEF.Growth high potential”, which validates Ecorobotix’s high growth strategy
Uncategorized 4FOX Ventures took part of the succesful USD 5M closing of the Serie A+ of our portfolio company Aspivix
Uncategorized Our portfolio company Ecorobotix won the gold medal in robotics and embedded electronics at the prestigious SIMA Innovation Awards 2022
Uncategorized Our portfolio company Positrigo just secured a first closing of CHF 5.5M for its series B round, welcoming new investors and bringing the total amount raised to date to CHF 13M
Uncategorized Despite all economic and geopolitical uncertainties, fundings for startups is at an all-time high.
Uncategorized Switzerland is the most innovative country in the world, ahead of the US and Sweden, said the World Intellectual Property Organization (WIPO)
Uncategorized Our portfolio company Scailyte has succesfully closed its Series A funding raising CHF 6 million from a Swiss family office, Mirabaud bank, and previous investors
Uncategorized Aspivix has received the European Medical Device Regulation QMS certification and is on track to obtain CE marking for their Suction Cervical Stabilizer
Uncategorized Welcome to Simon Aspinall who is now leading the ambitious development of our portfolio company Ecorobotix
Uncategorized Interesting podcast by Hui Yang Goh, Senior Advisor Alternative Investments at Pictet Wealth Management on why to invest in healthcare via private equity funds
Uncategorized Our portfolio company Artiria Medical secured a CHF 2.7M grant from one of the most competitive programs in Europe
Uncategorized Venture Capital Funding in Switzerland has experienced a tremendous growth over the past 10 years and is expected to keep booming
Uncategorized Our portfolio company Kairos Fire joined force with TF1 PUB to measure the impact of TV campaigns
Uncategorized Our portfolio company, Aspivix, achieved a new great milestone through the completion of the comparative clinical trial phase contributing
Uncategorized Our portfolio company, Neo Medical, closes Swisscom Ventures-lead USD 20.6M financing round
Uncategorized Go and read the latest interview of Vincent Lefauconnier, CEO of our portfolio company Neomedical
Uncategorized Our portfolio company Scailyte successfully closed its Serie A financing round, welcoming two additional new investors.
